TY - JOUR
T1 - Accuracy and reliability of eye-based vs quadrant-based diagnosis of plus disease in retinopathy of prematurity
AU - Imaging and Informatics in Retinopathy of Prematurity (i-ROP) Research Consortium
AU - Kim, Sang Jin
AU - Peter Campbell, J.
AU - Kalpathy-Cramer, Jayashree
AU - Ostmo, Susan
AU - Jonas, Karyn E.
AU - Choi, Dongseok
AU - Paul Chan, R. V.
AU - Chiang, Michael F.
AU - Sonmez, Kemal
AU - Horowitz, Jason
AU - Coki, Osode
AU - Eccles, Cheryl Ann
AU - Sarna, Leora
AU - Orlin, Anton
AU - Berrocal, Audina
AU - Negron, Catherin
AU - Denser, Kimberly
AU - Cumming, Kristi
AU - Osentoski, Tammy
AU - Check, Tammy
AU - Zajechowski, Mary
AU - Lee, Thomas
AU - Kruger, Evan
AU - McGovern, Kathryn
AU - Simmons, Charles
AU - Murthy, Raghu
AU - Galvis, Sharon
AU - Rotter, Jerome
AU - Chen, Ida
AU - Li, Xiaohui
AU - Taylor, Kent
AU - Roll, Kaye
AU - Erdogmus, Deniz
AU - Ioannidis, Stratis
AU - Martinez-Castellanos, Maria Ana
AU - Salinas-Longoria, Samantha
AU - Romero, Rafael
AU - Arriola, Andrea
AU - Olguin-Manriquez, Francisco
AU - Meraz-Gutierrez, Miroslava
AU - Dulanto-Reinoso, Carlos M.
AU - Montero-Mendoza, Cristina
N1 - Funding Information:
Funding/Support: This work is supported by
Funding Information:
This work is supported by grants R01EY019474, P30EY10572, and P41EB015896 from the National Institutes of Health, grants SCH-1622542, SCH-1622536, and SCH-1622679 from the National Science Foundation, and unrestricted departmental funding from Research to Prevent Blindness.
Funding Information:
completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Kalpathy-Cramer has received personal fees from Infotech Soft. Dr Chan has served as a consultant for Alcon, Allegan, and Bausch and Lomb and serves on the scientific advisory board for Visunex Medical Systems. Dr Chiang has received grants from the National Institutes of Health, National Science Foundation, and Research to Prevent Blindness, serves on the scientific advisory board for Clarity Medical Systems, and has served as a consultant for Novartis. No other disclosures were reported.
Publisher Copyright:
© 2018 American Medical Association. All rights reserved.
PY - 2018/6
Y1 - 2018/6
N2 - IMPORTANCE Presence of plus disease in retinopathy of prematurity is the most critical element in identifying treatment-requiring disease. However, there is significant variability in plus disease diagnosis. In particular, plus disease has been defined as 2 or more quadrants of vascular abnormality, and it is not clear whether it is more reliably and accurately diagnosed by eye-based assessment of overall retinal appearance or by quadrant-based assessment combining grades of 4 individual quadrants. OBJECTIVE To compare eye-based vs quadrant-based diagnosis of plus disease and to provide insight for ophthalmologists about the diagnostic process. DESIGN, SETTING, AND PARTICIPANTS In this multicenter cohort study, we developed a database of 197 wide-angle retinal images from 141 preterm infants from neonatal intensive care units at 9 academic institutions (enrolled from July 2011 to December 2016). Each image was assigned a reference standard diagnosis based on consensus image-based and clinical diagnosis. Data analysis was performed from February 2017 to September 2017. INTERVENTIONS Six graders independently diagnosed each of the 4 quadrants (cropped images) of the 197 eyes (quadrant-based diagnosis) as well as the entire image (eye-based diagnosis). Images were displayed individually, in random order. Quadrant-based diagnosis of plus disease was made when 2 or more quadrants were diagnosed as indicating plus disease by combining grades of individual quadrants post hoc. MAIN OUTCOMES AND MEASURES Intragrader and intergrader reliability (absolute agreement and ? statistic) and accuracy compared with the reference standard diagnosis. RESULTS Of the 141 included preterm infants, 65 (46.1%) were female and 116 (82.3%) white, and the mean (SD) gestational age was 27.0 (2.6) weeks. There was variable agreement between eye-based and quadrant-based diagnosis among the 6 graders (Cohen ? range, 0.32-0.75). Four graders showed underdiagnosis of plus disease with quadrant-based diagnosis compared with eye-based diagnosis (by McNemar test). Intergrader agreement of quadrant-based diagnosis was lower than that of eye-based diagnosis (Fleiss ?, 0.75 [95% CI, 0.71-0.78] vs 0.55 [95% CI, 0.51-0.59]). The accuracy of eye-based diagnosis compared with the reference standard diagnosis was substantial to near-perfect, whereas that of quadrant-based plus disease diagnosis was only moderate to substantial for each grader. CONCLUSIONS AND RELEVANCE Graders had lower reliability and accuracy using quadrant-based diagnosis combining grades of individual quadrants than with eye-based diagnosis, suggesting that eye-based diagnosis has advantages over quadrant-based diagnosis. This has implications for more precise definitions of plus disease regarding the criterion of 2 or more quadrants, clinical care, computer-based image analysis, and education for all ophthalmologists who manage retinopathy of prematurity.
AB - IMPORTANCE Presence of plus disease in retinopathy of prematurity is the most critical element in identifying treatment-requiring disease. However, there is significant variability in plus disease diagnosis. In particular, plus disease has been defined as 2 or more quadrants of vascular abnormality, and it is not clear whether it is more reliably and accurately diagnosed by eye-based assessment of overall retinal appearance or by quadrant-based assessment combining grades of 4 individual quadrants. OBJECTIVE To compare eye-based vs quadrant-based diagnosis of plus disease and to provide insight for ophthalmologists about the diagnostic process. DESIGN, SETTING, AND PARTICIPANTS In this multicenter cohort study, we developed a database of 197 wide-angle retinal images from 141 preterm infants from neonatal intensive care units at 9 academic institutions (enrolled from July 2011 to December 2016). Each image was assigned a reference standard diagnosis based on consensus image-based and clinical diagnosis. Data analysis was performed from February 2017 to September 2017. INTERVENTIONS Six graders independently diagnosed each of the 4 quadrants (cropped images) of the 197 eyes (quadrant-based diagnosis) as well as the entire image (eye-based diagnosis). Images were displayed individually, in random order. Quadrant-based diagnosis of plus disease was made when 2 or more quadrants were diagnosed as indicating plus disease by combining grades of individual quadrants post hoc. MAIN OUTCOMES AND MEASURES Intragrader and intergrader reliability (absolute agreement and ? statistic) and accuracy compared with the reference standard diagnosis. RESULTS Of the 141 included preterm infants, 65 (46.1%) were female and 116 (82.3%) white, and the mean (SD) gestational age was 27.0 (2.6) weeks. There was variable agreement between eye-based and quadrant-based diagnosis among the 6 graders (Cohen ? range, 0.32-0.75). Four graders showed underdiagnosis of plus disease with quadrant-based diagnosis compared with eye-based diagnosis (by McNemar test). Intergrader agreement of quadrant-based diagnosis was lower than that of eye-based diagnosis (Fleiss ?, 0.75 [95% CI, 0.71-0.78] vs 0.55 [95% CI, 0.51-0.59]). The accuracy of eye-based diagnosis compared with the reference standard diagnosis was substantial to near-perfect, whereas that of quadrant-based plus disease diagnosis was only moderate to substantial for each grader. CONCLUSIONS AND RELEVANCE Graders had lower reliability and accuracy using quadrant-based diagnosis combining grades of individual quadrants than with eye-based diagnosis, suggesting that eye-based diagnosis has advantages over quadrant-based diagnosis. This has implications for more precise definitions of plus disease regarding the criterion of 2 or more quadrants, clinical care, computer-based image analysis, and education for all ophthalmologists who manage retinopathy of prematurity.
UR - http://www.scopus.com/inward/record.url?scp=85048787689&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85048787689&partnerID=8YFLogxK
U2 - 10.1001/jamaophthalmol.2018.1195
DO - 10.1001/jamaophthalmol.2018.1195
M3 - Article
C2 - 29710185
AN - SCOPUS:85048787689
SN - 2168-6165
VL - 136
SP - 648
EP - 655
JO - JAMA ophthalmology
JF - JAMA ophthalmology
IS - 6
ER -